Medtronic (NYSE:MDT) this week launched a cloud-based data management software platform for its Synchromed II drug delivery system.
The Efficio platform is designed to allow clinicians to manage targeted drug delivery pump practices to treat patients who have chronic pain, cancer pain and severe spasticity. It consolidates, organizes and provides visual summaries of patient data received from the clinician programmer in a secure cloud environment. The information is accessible anywhere and at any time.
“For years, clinicians have been managing pump patients on their own with internal spreadsheets and other manual processes,” Chris Beuer, director of pain management at Christian Hospital in St. Louis, Mo., said in a news release. “Now, with the click of a button, I can understand the dosing history of an individual patient or produce end-of-day reports within minutes. Efficio also helps me manage pump refill dates, pump replacement and monitor trends in dosing and patient function. It provides tremendous value to my practice, allowing me to focus more time caring for my patients.”
Efficio is able to connect individual patient measurements and dosing trends for better therapy management insights. It also enables scheduling patient appointments, facilitates prescription drug order tracking for pump refills and can print reports on demand.
“Efficio marks another step in our journey to simplify targeted drug delivery therapy,” VP and general manager of target drug delivery at Medtronic Charlie Covert said. “We believe providing innovative solutions that simplify management of the therapy will enable clinicians to reduce pain or severe spasticity symptoms for even more patients with this proven therapy.”
Medtronic in October last year recalled an unspecified number of its SynchroMed II drug infusion pumps because of a possibility of malfunction. The company also warned in 2017 on batteries first issued in 2011 that could cause the pump to fail.
